Hong Kong, China vs United States of America: Treatment success rate: XDR-TB cases
Hong Kong, China
100
in 2022
United States of America
100
in 2021
Hong Kong, China rank
1st
United States of America rank
1st
Treatment success rate: XDR-TB cases over time
- Hong Kong, China
- United States of America
How they compare
Hong Kong, China currently reports 100 against 100 in United States of America, a difference of 0.
The two have swapped places 5 times across 9 shared years of data; in 2010 it was Hong Kong, China ahead.
Hong Kong, China ranks 1st and United States of America ranks 1st of 82 countries.
Hong Kong, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong, China | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81 | 64 | 17 | Hong Kong, China |
| 2020s | 83.5 | 50 | 33.5 | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Hong Kong, China or United States of America?
- Hong Kong, China, at 100 against 100 in United States of America as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Hong Kong, China and United States of America?
- 0, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and United States of America?
- 9 years are reported by both, from 2010 to 2021.
- How do Hong Kong, China and United States of America rank globally for treatment success rate: xdr-tb cases?
- Hong Kong, China ranks 1st and United States of America ranks 1st of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.